| a comparison of the genie and western blot assays in confirmatory testing for hiv-1 antibody. | the genie hiv-1/2 kit (sanofi diagnostics pasteur, montreal, quebec), a synthetic-peptide solid-phase enzyme immunoassay, was evaluated as a confirmatory assay for hiv-1 antibodies in comparison with western blot (biorad, hercules, ca, usa) on 50 stored hiv-1 antibody-positive sera and the 137 sera yielding repeated positive results in the conventional eia screen out of 13405 fresh patient sera from saskatchewan in 1993. the stored hiv-1-positive sera were uniformly positive in the genie test. o ... | 1996 | 8636942 |
| predictors of antiviral therapy in a post-transfusion cohort of hepatitis c patients. | in the past, antiviral therapy has been given to 15% to 30% of patients infected with hepatitis c virus (hcv). the efficacy of therapy has recently improved with the addition of ribavirin and pegylated interferon. the aim of the present study was to identify the clinical, socioeconomic and health-system predictors of antiviral treatment for hcv. | 2006 | 16482237 |
| risk behaviours for infection with hiv and hepatitis c virus among people who inject drugs in regina, saskatchewan. | | 2007 | 17520768 |
| risk indicators of depressive symptomatology among injection drug users and increased hiv risk behaviour. | objectives: in 2009, the annual incidence of positive human immunodeficiency virus (hiv) test reports for people in the saskatoon health region (shr) was 31.3 per 100 000, when the national average was only 9.3 per 100 000. the first objective was to determine the prevalence of depressive symptomatology among injection drug users (idus) in the shr. the second objective was to determine the unadjusted and adjusted risk indicators associated with depressive symptomatology among idus. the third obj ... | 2011 | 21756450 |